Deep radiomic signature with immune cell markers predicts the survival of glioma patients.
Ahmad ChaddadPaul DanielMingli ZhangSaima RathorePaul SargosChristian DesrosiersTamim NiaziPublished in: CoRR (2022)
Keyphrases
- clinical data
- immune response
- survival prediction
- survival data
- breast cancer patients
- kaplan meier
- immune cells
- medical data
- patient data
- anomaly detection
- cancer patients
- statistical analysis
- breast cancer
- high risk
- signature recognition
- signature verification
- raw data
- normal subjects
- artificial immune
- gene sets
- knowledge discovery
- clinical trials
- image data